Ferrer Doses First Participant in Phase 2 Study for PSP Treatment

Text: Ferrer Doses First Participant in Phase 2 Study for PSP Treatment. Background: A person pours pills into another person's hand.

Pharmaceutical company Ferrer announced that it has dosed the first participant in the PROSPER phase 2 clinical trial for an experimental treatment for progressive supranuclear palsy. The ongoing trial seeks to evaluate the safety and efficacy of the drug FNP-223, which is designed to slow the progression of the disease. The drug works to prevent…

Læs mere

Personer med FTD Advisory Council Specialartikel: Holiday Madness

Persons with FTD Advisory Council Special Article: Holiday Madness Photo of Cindy Odell smiling and wearing a gray, charcoal, black, red, and burgundy sweater.

This article was written by a person with FTD to highlight the challenges of dealing with the holidays with an FTD diagnosis. AFTD hopes care partners and those diagnosed can benefit from the perspective presented here. By Cindy Odell, former Council member All holidays can be stressful for anyone at any time. It doesn’t matter…

Læs mere

Alt i familien for at afslutte FTD: Colonial Electric's Food for Thought-begivenhed rydder mere end $1 million siden starten

Patricia "Trish" Bellwoar, who had FTD, smiles as she sits in a wheelchair being pushed by her husband, Joseph Bellwoar.

AFTD Board alumnus, Steve Bellwoar, has raised more than $1 million to drive AFTD’s mission in memory of his mother. Patricia “Trish” Bellwoar died in 2021 after living with FTD for nearly 30 years. Since Steve’s initial Colonial Electric Food for Thought gathering in 2014, the event, which features a nine-hole golf tournament, cocktail hour,…

Læs mere

En samtale med en neurolog hos Denali Therapeutics

Graphic: A Conversation with a Neurologist at Denali Therapeutics. Background: A photo of Dr. Richard Tsai

Recently, AFTD had a conversation with members of the Denali Therapeutics team, including Dr. Richard Tsai, to provide insights into their work to develop a therapeutic with Takeda to treat FTD-GRN (frontotemporal dementia caused by GRN gene mutations). Dr. Tsai is a neurologist at Denali where he partners with other scientists to design and conduct…

Læs mere

AFTD Advocacy: State Resolution Training

Denne træning vil dække processen for, hvordan man opnår en beslutning - fra at identificere dine lovgivere til at modtage din godkendte beslutning. Det vil også dække pressestrategier for at maksimere synlighed og skabe mere bevidsthed om FTD i din stat. Deltagerne vil modtage og gennemgå: 2025 Resolution Toolkit Resolution language Presseværktøjssæt Advocacy talking...

Læs mere

Perspektiver i FTD Webinar: FTD Research 2024 — Hvor vi er kommet fra, og hvor vi er på vej hen

Videnskaben om FTD udvikler sig i et hurtigt tempo, og det kan være svært at fortolke de videnskabelige fremskridt, og hvordan de kan påvirke familier, der står over for en FTD-diagnose. I dette webinar for Perspectives in FTD Research, præsenteret i fællesskab af AFTD og FTD Disorders Registry, AFTDs seniordirektør for videnskabelige initiativer, Penny Dacks, PhD,...

Læs mere